Upstate Active Clinical Trials
Study Title:Alliance A151216 - Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
What is the purpose of the study?This research trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Upstate Institutional Review Board (IRB) Number:652783
Patient Age Group:Adults
Principal Investigator:Stephen L Graziano, MD
Where will the study take place?Upstate Cancer Center-All procedures
Who can I contact for more information?
Name: Erinn Mcdowell, MS, CCRP